This is a research study to test a new investigational drug, LPCN 1154A, brexanolone. The study is being conducted to test how LPCN 1154A affects women with postpartum depression. The study drug LPCN 1 154A contains brexanolone identical to the allopregnanolone your body makes.

The purpose of this research is to investigate the safety and effectiveness of an investigational medical device for the treatment of infertility in women with polycystic ovary syndrome (PCOS).

The purpose of this study is to determine the safety and effectiveness of the MorpheusV Applicator for the treatment of overactive bladder (OAB) symptoms, including OAB, which has not responded to other treatments. The procedure that you will undergo with the MorpheusV Applicator uses radiofrequency heat to affect and possibly improve the functionality of the abnormal nerve endings causing OAB.

This is a study of an investigational device called the SUl-100 that has been developed for strengthening the urethral sphincter muscles (muscles around the urethra) in women with stress urinary incontinence. In the study, the SUl-100 device will be used to perform a series of treatments called acoustic pulse therapy. Acoustic pulse therapy uses energy from focused sound waves to stimulate tissue. The purpose of this study is to determine if these treatments will strengthen the muscles around the urethra to relieve the symptoms of stress urinary incontinence.